MENU
+Compare
IMNM
Stock ticker: NASDAQ
AS OF
Apr 4 closing price
Price
$5.93
Change
-$0.31 (-4.97%)
Capitalization
515.62M

IMNM Immunome Forecast, Technical & Fundamental Analysis

Immunome Inc is a biopharmaceutical company... Show more

IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IMNM with price predictions
Apr 04, 2025

IMNM's Stochastic Oscillator is sitting in oversold zone for 12 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMNM advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

IMNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IMNM as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IMNM turned negative on March 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMNM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IMNM entered a downward trend on April 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.846) is normal, around the industry mean (13.044). P/E Ratio (0.000) is within average values for comparable stocks, (63.096). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.822). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (38.462) is also within normal values, averaging (249.684).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IMNM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMNM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IMNM is expected to report earnings to fall 40.51% to -66 cents per share on May 08

Immunome IMNM Stock Earnings Reports
Q1'25
Est.
$-0.66
Q4'24
Missed
by $0.45
Q3'24
Missed
by $0.24
Q2'24
Missed
by $0.22
Q1'24
Missed
by $1.83
The last earnings report on March 19 showed earnings per share of -111 cents, missing the estimate of -66 cents. With 1.11M shares outstanding, the current market capitalization sits at 515.62M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HOOSX25.82-1.08
-4.01%
Hartford Schroders US Small Cap Opps R4
SCRYX9.89-0.43
-4.17%
AB Small Cap Core Advisor
SHDRX8.01-0.42
-4.98%
American Beacon Shapiro SMID Cap Eq R6
JDNRX58.87-3.59
-5.75%
Janus Henderson Growth And Income R
AFNAX22.82-1.42
-5.86%
Bahl & Gaynor Income Growth A

IMNM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-4.97%
KYMR - IMNM
53%
Loosely correlated
-6.84%
IDYA - IMNM
51%
Loosely correlated
-5.52%
BEAM - IMNM
51%
Loosely correlated
-7.23%
RXRX - IMNM
49%
Loosely correlated
-11.85%
CCCC - IMNM
49%
Loosely correlated
-4.73%
More